Annalise ai Introduces Radiology Triage Platform for Head CT and Chest X-Ray Exams

News
Article

Featuring 12 prior FDA clearances for chest X-ray and non-contrast head CT, the Annalise Triage platform may help streamline radiology workflows and prioritize timely diagnosis of urgent conditions.

Offering an artificial intelligence (AI)-powered modality to help prioritize head computed tomography (CT) and chest X-ray exams on radiology worklists, Annalise.ai has launched the Annalise Triage software platform.

The Annalise Triage modality includes 12 prior clearances from the Food and Drug Administration (FDA) for unenhanced head CT and chest X-ray, facilitating timely detection of conditions ranging from acute subdural hematoma and tension pneumothorax to pneumoperitoneum and obstructive hydrocephalus, according to Annalise.ai.

For busy radiologists faced with daunting imaging volumes amid ongoing radiologist shortages, Annalise.ai said the adjunctive AI capabilities with Annalise Triage can enhance worklist prioritization for cases involving chest X-rays and head CT scans.

“Our advanced algorithms support radiologists by facilitating prioritization of studies with suspected critical findings, thereby optimizing radiology workflow,” noted Rick Abramson, M.D., MHCDS, FACR, the chief medical officer at Annalise.ai. “With its set of clearances, Annalise.ai promotes faster report turnaround times by identifying and elevating critical cases for immediate attention.”

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Related Content
© 2025 MJH Life Sciences

All rights reserved.